This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n11http://linked.opendata.cz/resource/drugbank/drug/DB07460/identifier/drugbank/
n14http://linked.opendata.cz/resource/drugbank/drug/DB07460/identifier/chemspider/
n13http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n6http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n12http://linked.opendata.cz/resource/drugbank/drug/DB07460/identifier/pdb/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n9http://linked.opendata.cz/resource/drugbank/drug/DB07460/identifier/pubchem-compound/
n10http://linked.opendata.cz/resource/drugbank/drug/DB07460/identifier/pubchem-substance/

Statements

Subject Item
n2:DB07460
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n6:DB07460 n13:DB07460
dcterms:title
2-({5-CHLORO-2-[(2-METHOXY-4-MORPHOLIN-4-YLPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)-N-METHYLBENZAMIDE
adms:identifier
n9:9934347 n10:99443931 n11:DB07460 n12:BI9 n14:8109975
n3:IUPAC-Name
n4:271B4669-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B466F-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B466E-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B466B-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B466C-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B466D-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B4667-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B4665-363D-11E5-9242-09173F13E4C5 n4:271B4668-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B4666-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B4675-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B4676-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B4670-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B4671-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B4673-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B4672-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B4674-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B467B-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B467D-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B467E-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B467A-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B4679-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B467C-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B466A-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B4677-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B4678-363D-11E5-9242-09173F13E4C5